Market Cap | 700.70M | P/E | - | EPS this Y | 27.30% | Ern Qtrly Grth | - |
Income | -69.85M | Forward P/E | -16.73 | EPS next Y | - | 50D Avg Chg | - |
Sales | 87.24M | PEG | -0.68 | EPS past 5Y | - | 200D Avg Chg | -19.00% |
Dividend | N/A | Price/Book | 0.62 | EPS next 5Y | 45.80% | 52W High Chg | -49.00% |
Recommedations | 2.80 | Quick Ratio | 21.54 | Shares Outstanding | 381.30M | 52W Low Chg | 11.00% |
Insider Own | 46.57% | ROA | -4.25% | Shares Float | 203.82M | Beta | 1.12 |
Inst Own | 13.10% | ROE | -6.30% | Shares Shorted/Prior | 5.62M/6.44M | Price | 1.84 |
Gross Margin | 13.65% | Profit Margin | -84.78% | Avg. Volume | 1,515,354 | Target Price | 2.61 |
Oper. Margin | -75.97% | Earnings Date | May 9 | Volume | 1,205,901 | Change | -3.66% |
Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
B of A Securities | Underperform | Apr 8, 24 |
B of A Securities | Underperform | Dec 28, 23 |
Barclays | Equal-Weight | May 15, 23 |
Bernstein | Market Perform | Nov 2, 22 |
Barclays | Equal-Weight | Sep 30, 22 |
Barclays | Equal-Weight | Mar 22, 22 |
Piper Sandler | Neutral | Mar 7, 22 |
Canaccord Genuity | Sell | Feb 22, 22 |
Piper Sandler | Neutral | Feb 22, 22 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
ADLER JASON MARC | Director Director | May 25 | Buy | 1.8 | 100,000 | 180,000 | 1,376,054 | 05/30/23 |
ADLER JASON MARC | Director Director | Nov 28 | Buy | 3.03 | 52,900 | 160,287 | 467,216 | 12/01/22 |
ADLER JASON MARC | Director Director | Nov 22 | Buy | 3.04 | 53,300 | 162,032 | 430,186 | 11/25/22 |
GORENSTEIN MICHAEL RYAN | See remarks below See remarks below | Aug 22 | Option | 2.42 | 62,500 | 151,250 | 9,506,812 | 08/26/22 |
ADLER JASON MARC | Director Director | Aug 17 | Option | 2.42 | 500,000 | 1,210,000 | 8,931,654 | 08/23/22 |
JACOBSON JEFFREY DAVID | See Remarks See Remarks | Apr 04 | Option | 2.51 | 20,000 | 50,200 | 99,186 | 04/06/22 |
ADLER JASON MARC | Director Director | Mar 16 | Option | 3.14 | 1,300,000 | 4,082,000 | 9,465,072 | 03/18/22 |
GORENSTEIN MICHAEL RYAN | Executive Chairman Executive Chairman | Mar 16 | Option | 3.14 | 27,084 | 85,044 | 9,467,596 | 03/18/22 |